NovogeneAIT Genomics Singapore Pte Ltd was formed in 2017. We are the combination of Novogene China and AITbiotech in Singapore, two of the most experienced providers of DNA sequencing solutions in Asia and globally.
At NovogeneAIT, we are proud to offer the broadest options in Next Generation Sequencing (NGS) services using the latest technologies in the market. Our NGS services are available on leading sequencing platforms, Illumina (HiSeq, NextSeq and MiSeq) and Life Technologies (Ion Proton and Ion PGM), and we have extensive expertise using these platforms in a wide array of NGS sequencing projects.
We are one of the first companies to offer HiSeq X Five sequencing capabilities in Southeast Asia for whole genome sequencing of human, plants and animals – capable of sequencing 9,000 whole genomes per year at the lowest cost per genome. NovogeneAIT’s data analysis capabilities are unmatched among NGS service providers – led by Novogene founder and CEO, Dr. Ruiqiang Li, one of the world’s leading experts in genomics and bioinformatics. His exceptional bioinformatics expertise and commitment to delivering information and solutions to our customers is a cornerstone of Novogene’s success. Dr. Li owns 8 patents and has authored over 70 publications that have been cited more than 12,000 times. Novogene has 34 patents related to NGS analysis and processes. NovogeneAIT uses the most widely-accepted and highly-regarded public software/algorithms as well as Novogene patented and proprietary software for analysis.
With labs at both Biopolis and Pandan Crescent in Singapore and fully supported in Singapore by a team of technical staff and scientists experienced in this fast evolving technology – and over 1000 person team at Novogene China – we will assist you in selecting the best sequencing platform and solutions for your specific needs. Leverage on our expertise and contact us today for a free, no-obligation consultation.